CMTU
NVO

Capital Markets Trading (UK)’s Novo Nordisk NVO Stock Holding History

Capital Markets Trading (UK)’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$416K Sell
8,679
-3,631
-29% -$156K ﹤0.01% 325
2026
Q1 		$452K Buy
+12,310
New +$583K 0.01% 282
2025
Q4 		– Sell
-3,946
Closed -$202K – 327
2025
Q3 		$219K Buy
+3,946
New +$231K ﹤0.01% 286

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Capital Markets Trading (UK)'s NVO Position: Q2 2026 in Review

Capital Markets Trading (UK) reduced its Novo Nordisk (NVO) stake by 29% in Q2 2026, selling an estimated $156K and leaving 8,679 shares worth $416K. The position accounts for ﹤0.01% of the portfolio, ranked #325.

Capital Markets Trading (UK) first reported a position in NVO in Q3 2025 and has held it in 3 quarters since. The position peaked at $452K in Q1 2026. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Capital Markets Trading (UK) held 8,679 shares of Novo Nordisk worth $416K as of Q2 2026.
  • Capital Markets Trading (UK) sold 3,631 Novo Nordisk shares in Q2 2026, an estimated $156K.
  • Novo Nordisk made up ﹤0.01% of Capital Markets Trading (UK)'s portfolio in Q2 2026, its #325 holding.
  • Capital Markets Trading (UK) first reported a position in Novo Nordisk in Q3 2025 and has held it in 3 quarters since.
  • Capital Markets Trading (UK)'s Novo Nordisk position peaked at $452K in Q1 2026.
  • 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Capital Markets Trading (UK)'s 13F filing for Q2 2026, filed 13 Aug 2026.